Compare ACNB & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACNB | ACB |
|---|---|---|
| Founded | 1857 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 659.3M | 232.3M |
| IPO Year | 1994 | 2016 |
| Metric | ACNB | ACB |
|---|---|---|
| Price | $62.25 | $4.05 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $58.00 | N/A |
| AVG Volume (30 Days) | 47.4K | ★ 792.2K |
| Earning Date | 04-23-2026 | 06-17-2026 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.81 | N/A |
| Revenue | ★ $191,821,000.00 | N/A |
| Revenue This Year | $13.18 | $6.31 |
| Revenue Next Year | $1.91 | N/A |
| P/E Ratio | $22.48 | ★ N/A |
| Revenue Growth | ★ 45.10 | N/A |
| 52 Week Low | $42.60 | $2.56 |
| 52 Week High | $67.60 | $6.67 |
| Indicator | ACNB | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 59.25 |
| Support Level | $48.10 | $3.27 |
| Resistance Level | $65.62 | $4.15 |
| Average True Range (ATR) | 1.38 | 0.13 |
| MACD | -0.29 | -0.01 |
| Stochastic Oscillator | 7.64 | 59.68 |
ACNB Corp is the financial holding company. Through its wholly-owned subsidiaries, it provides a full range of retail and commercial financial services in Pennsylvania and Maryland through its network of community banking offices. It also provides property, casualty, health, life and disability insurance serving personal and commercial clients through offices in Westminster, Maryland, and Gettysburg, Pennsylvania and is licensed to do business. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage; and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.